| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.26B | -9.1% |
| Cost of Revenue | $9.77B | -20.7% |
| Gross Profit | $6.50B | +16.5% |
| R&D Expense | $662.2M | -11.8% |
| SG&A Expense | $4.18B | -7.7% |
| Operating Income | $1.61B | +4849.7% |
| Interest Expense | $592.4M | -6.9% |
| Pre-tax Income | $2.81B | +523.4% |
| Income Tax | $734.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.26B | +79.7% |
| Accounts Receivable | $3.81B | -10.6% |
| Inventory | $3.52B | -11.5% |
| Current Assets | $10.64B | -2.5% |
| Total Assets | $50.02B | -8.8% |
| Current Liabilities | $6.75B | -31.7% |
| Long-term Debt | $18.02B | -8.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.95B | -2.1% |
| Capital Expenditures | $406.0M | -11.2% |
| Investing Cash Flow | $1.52B | +1390.7% |
| Financing Cash Flow | -$3.88B | -28.7% |
| Free Cash Flow | $2.55B | -0.5% |
| +21.5% |
| Net Income | $2.08B | +263.8% |
| EPS (Basic) | $1.71 | +262.9% |
| EPS (Diluted) | $1.71 | +262.9% |
| Total Liabilities |
| $28.95B |
| -15.7% |
| Stockholders' Equity | $21.07B | +2.8% |